CMPS COMPASS Pathways Plc - American Depository Shares
$13,94
Prix · Aoû 19, 2026
Données fondamentales au Aoû 5, 2026
Fourchette 52 semaines
$4–$15
87% of range
Note des analystes
BUY
24 analysts
Objectif de cours
$24
+70% upside
P/E (TTM)
-4.5
ROE
-524.8%
Marge nette
—
À propos de COMPASS Pathways Plc - American Depository Shares Présentation de l'entreprise depuis Wikipedia
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Lire la suite
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.
Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.
Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
CMPS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$13.94
Capitalisation Boursière
$1.34B
P/E (TTM)
-4.5
BPA (TTM)
$-3.08
Revenus (TTM)
—
Rendement div.
—
ROE
-524.8%
Dette/Capitaux propres
-0.6
Fourchette 52 semaines
$4 – $15
CMPS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-3.08
2019-12-31
→
2025-12-31
Flux de trésorerie libre
—
2021-12-31
→
2024-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CMPS
Médiane des pairs
P/E (TTM)
-4.5
66.9
P/B
-25.3
3.7
EV / EBITDA
-6.8
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CMPS
Médiane des pairs
ROA
-135.8%
-23.9%
ROE
-524.8%
-27.7%
ROIC
836.7%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CMPS
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
-0.6
4.4
Current Ratio (Ratio de liquidité)
0.8
4.0
Quick Ratio (Ratio de liquidité réduite)
0.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CMPS
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CMPS
Médiane des pairs
CMPS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
24 analystes
- Achat fort 8 33,3%
- Achat 14 58,3%
- Conserver 2 8,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
16 analystes · 2026-08-16
Médiane
$21.00
Maintenant
$13.94
Bas
$13.00
Haut
$65.00
Objectif médian
$21.00
+50,6%
Objectif moyen
$23.75
+70,4%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.27%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-1.88 | $-0.41 | -1.5% |
| 31 mars 2026 | $0.71 | $-0.39 | 1.1% |
| 31 décembre 2025 | $-1.00 | $-0.40 | -0.60% |
| 30 septembre 2025 | $-1.44 | $-0.40 | -1.0% |
| 30 juin 2025 | $-0.41 | $-0.44 | 0.03% |
| 31 mars 2025 | $-0.38 | $-0.48 | 0.10% |
| 31 décembre 2024 | $-0.63 | $-0.64 | 0.01% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
| BDRX | — | — | — | — | — | — |
| KNSA | $3.15B | 55.0 | 60.1% | 8.7% | 11.1% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $118M | $119M | $88M | $65M | $44M | $23M | |
| SG&A Expense | $61M | $59M | $49M | $45M | $39M | $28M | |
| Operating Expenses | $179M | $178M | $137M | $110M | $83M | $51M | |
| Operating Income | $-179M | $-178M | $-137M | $-110M | $-83M | $-51M | |
| Interest Expense | · | · | $2M | $0 | $0 | · | |
| Interest Income | $7M | $8M | $5M | · | · | · | |
| Other Non-op | $1M | $823.0K | $255.0K | $19M | $12M | $-9M | |
| Pretax Income | $-290M | $-154M | $-118M | $-91M | $-72M | $-60M | |
| Income Tax | $-2M | $2M | $780.0K | $408.0K | $199.0K | $32.0K | |
| Net Income | $-288M | $-155M | $-118M | $-92M | $-72M | $-60M | |
| EPS (Basic) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| EPS (Diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| Shares (Basic) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| Shares (Diluted) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| EBITDA | $-179M | $-178M | $-137M | $-110M | $-83M | · |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $165M | $220M | $143M | $273M | $190M | |
| Prepaid Expense | $42M | $36M | $41M | $48M | $22M | $12M | |
| Other Current Assets | $6M | $4M | $2M | $1M | $1M | $509.0K | |
| Current Assets | $191M | $201M | $261M | $192M | $295M | $202M | |
| PP&E (Net) | · | $189.0K | $423.0K | $617.0K | $398.0K | $245.0K | |
| PP&E (Gross) | · | · | · | $1M | $756.0K | $433.0K | |
| Accum. Depreciation | · | · | · | $530.0K | $358.0K | $188.0K | |
| Other Non-current Assets | $12M | $7M | $7M | $1M | $213.0K | $57.0K | |
| Total Assets | $210M | $214M | $276M | $197M | $301M | $203M | |
| Accounts Payable | $15M | $12M | $6M | $5M | $3M | $3M | |
| Current Liabilities | $248M | $34M | $20M | $16M | $15M | $7M | |
| Capital Leases | $1M | $303.0K | $2M | $418.0K | $1M | · | |
| Total Liabilities | $263M | $59M | $50M | $16M | $16M | $7M | |
| Long-term Debt | $32M | $30M | $29M | $0 | · | · | |
| Total Debt | $32M | $30M | · | · | · | · | |
| Common Stock | $973.0K | $702.0K | $635.0K | · | · | · | |
| Paid-in Capital | $784M | $705M | $622M | $459M | $445M | $279M | |
| Retained Earnings | $-823M | $-535M | $-380M | $-261M | $-170M | $-98M | |
| AOCI | $-15M | $-16M | $-17M | $-17M | $9M | $15M | |
| Stockholders' Equity | $-53M | $155M | $226M | $181M | $284M | $197M | |
| Liabilities + Equity | $210M | $214M | $276M | $197M | $301M | $203M | |
| Shares Outstanding | 96,085,785 | 68,552,215 | 61,943,471 | · | · | · |
Flux de trésorerie 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | $242.0K | $330.0K | $175.0K | $112.0K | |
| Stock-based Comp | $14M | $20M | $17M | $13M | $9M | $18M | |
| Deferred Tax | $22.0K | $-437.0K | $-1M | $-1M | $-545.0K | $-221.0K | |
| Other Non-cash | · | · | $5M | $-26M | $-4M | · | |
| Operating Cash Flow | $-157M | $-119M | $-97M | $-105M | $-68M | $-41M | |
| CapEx | · | $0 | $66.0K | $596.0K | $334.0K | $131.0K | |
| Investing Cash Flow | · | $0 | $-64.0K | $-596.0K | $-334.0K | $-628.0K | |
| Debt Issued | · | $0 | $30M | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $30M | · | · | · | |
| Stock Issued | $140M | $26M | $145M | $440.0K | $155M | $0 | |
| Net Stock Activity | $140M | $26M | $145M | $440.0K | $155M | · | |
| Financing Cash Flow | $141M | $64M | $174M | $1M | $157M | $194M | |
| Net Change in Cash | $-15M | $-55M | $77M | $-130M | $83M | $165M | |
| Taxes Paid | $755.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-119M | $-97M | $-106M | $-68M | · | |
| Levered FCF | · | · | $-100M | · | · | · |
Rentabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | · | |
| ROE | -524.8% | -89.2% | -49.5% | -48.7% | -24.3% | · | |
| ROIC | 836.7% | -97.4% | -61.1% | -61.2% | -29.3% | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 | · | |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 | · | |
| Debt / Equity | -0.6 | 0.2 | · | · | · | · | |
| LT Debt / Equity | -0.3 | 0.2 | · | · | · | · | |
| Interest Coverage | · | · | -62.1 | · | · | · |
Valorisation (TTM) 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-288M | $-155M | $-118M | $-92M | $-72M | · | |
| Market Cap | $663M | $259M | · | · | · | · | |
| Enterprise Value | $545M | $124M | · | · | · | · | |
| P/E | -2.2 | -1.6 | -3.8 | -3.7 | -12.3 | · | |
| P/B | -12.5 | 1.7 | · | · | · | · | |
| P / Tangible Book | · | 1.7 | · | · | · | · | |
| P / Cash Flow | -4.2 | -2.2 | · | · | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | |
| EV / EBITDA | -3.0 | -0.7 | · | · | · | · | |
| EV / FCF | · | -1.0 | · | · | · | · | |
| Earnings Yield | -44.6% | -60.9% | -26.5% | -26.9% | -8.1% | · |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $26M | $30M | $27M | $30M | $31M | $32M | $33M | $29M | $25M | $27M | $22M | $20M | $19M | $20M | $14M | |
| SG&A Expense | $23M | $16M | $16M | $13M | $13M | $19M | $16M | $15M | $14M | $14M | $11M | $13M | $13M | $13M | $12M | $12M | |
| Operating Expenses | $52M | $43M | $46M | $41M | $43M | $50M | $48M | $48M | $43M | $39M | $38M | $34M | $33M | $32M | $32M | $26M | |
| Operating Income | $-52M | $-43M | $-46M | $-41M | $-43M | $-50M | $-48M | $-48M | $-43M | $-39M | $-38M | $-34M | $-33M | $-32M | $-32M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | · | $0 | $0 | $0 | |
| Interest Income | $4M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $638.0K | · | · | · | |
| Other Non-op | $546.0K | $484.0K | $370.0K | $383.0K | $-176.0K | $803.0K | $337.0K | $191.0K | $167.0K | $128.0K | $-8M | $112.0K | $-11.0K | $8M | $1M | $7M | |
| Pretax Income | $-253M | $91M | $-97M | $-138M | $-38M | $-18M | $-42M | $-38M | $-38M | $-35M | $-32M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| Income Tax | $331.0K | $-11.0K | $-3M | $-230.0K | $137.0K | $354.0K | $1M | $173.0K | $176.0K | $222.0K | $394.0K | $62.0K | $194.0K | $130.0K | $92.0K | $120.0K | |
| Net Income | $-254M | $91M | $-94M | $-138M | $-38M | $-18M | $-43M | $-39M | $-38M | $-35M | $-33M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| EPS (Basic) | $-1.88 | $0.71 | $-1.03 | $-1.44 | $-0.41 | $-0.20 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| EPS (Diluted) | $-1.88 | $-0.30 | $-0.99 | $-1.44 | $-0.41 | $-0.24 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| Shares (Basic) | 135,039,810 | 110,064,581 | -184,367,003 | 95,337,993 | 93,341,594 | 89,192,252 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| Shares (Diluted) | 135,039,810 | 130,266,693 | -193,816,374 | 95,337,993 | 93,341,594 | 98,641,623 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| EBITDA | $-52M | $-43M | · | $-41M | $-43M | $-50M | · | $-48M | $-43M | $-39M | · | $-34M | $-33M | $-32M | · | $-25M |
Bilan 22
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $433M | $466M | $150M | $186M | $222M | $260M | $165M | $207M | $229M | $263M | $220M | $248M | $148M | $117M | $143M | $173M | |
| Prepaid Expense | $42M | $44M | $42M | $56M | $54M | $45M | $36M | $26M | $36M | $31M | $41M | $36M | $45M | $50M | $48M | $45M | |
| Other Current Assets | $8M | $7M | $6M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $476M | $511M | $191M | $242M | $276M | $305M | $201M | $234M | $265M | $296M | $261M | $285M | $194M | $168M | $192M | $218M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $359.0K | $423.0K | $309.0K | $482.0K | $612.0K | $617.0K | $555.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $395.0K | |
| Other Non-current Assets | $20M | $14M | $12M | $5M | $9M | $8M | $7M | $7M | $6M | $6M | $7M | $6M | $7M | $212.0K | $1M | $299.0K | |
| Total Assets | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Accounts Payable | $12M | $11M | $15M | $5M | $11M | $9M | $12M | $8M | $8M | $9M | $6M | $4M | $2M | $4M | $5M | $20M | |
| Current Liabilities | $367M | $154M | $248M | $197M | $31M | $30M | $34M | $26M | $22M | $19M | $20M | $15M | $13M | $11M | $16M | $30M | |
| Capital Leases | $2M | $779.0K | $1M | $2M | $2M | $259.0K | $303.0K | $459.0K | $799.0K | $1M | $2M | $2M | $3M | $412.0K | $418.0K | $425.0K | |
| Total Liabilities | $420M | $205M | $263M | $218M | $131M | $124M | $59M | $54M | $52M | $50M | $50M | $46M | $43M | $12M | $16M | $30M | |
| Long-term Debt | $51M | $50M | $32M | $31M | $31M | $31M | $30M | $30M | $29M | $29M | $29M | $28M | $28M | · | $0 | · | |
| Total Debt | $51M | $50M | · | $31M | $31M | $31M | · | $28M | · | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $973.0K | $973.0K | $946.0K | $938.0K | $702.0K | $699.0K | $699.0K | $699.0K | $635.0K | · | · | · | · | · | |
| Paid-in Capital | $1.08B | $1.07B | $784M | $781M | $767M | $763M | $705M | $700M | $695M | $690M | $622M | $617M | $496M | $464M | $459M | $455M | |
| Retained Earnings | $-985M | $-731M | $-823M | $-729M | $-591M | $-553M | $-535M | $-491M | $-453M | $-415M | $-380M | $-347M | $-314M | $-285M | $-261M | $-230M | |
| AOCI | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-31M | |
| Stockholders' Equity | $85M | $327M | $-53M | $38M | $163M | $195M | $155M | $193M | $226M | $259M | $226M | $253M | $166M | $162M | $181M | $195M | |
| Liabilities + Equity | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Shares Outstanding | 135,722,306 | 134,923,295 | 96,085,785 | 96,002,044 | 93,586,348 | 92,848,326 | 68,552,215 | 68,409,068 | 68,387,469 | 68,342,534 | 61,943,471 | · | · | · | · | · |
Flux de trésorerie 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $59.0K | $63.0K | $61.0K | · | $186.0K | $110.0K | $48.0K | $76.0K | $100.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $9M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-40M | $-48M | $-38M | $-35M | $-39M | $-46M | $-42M | $-22M | $-34M | $-21M | $-28M | $-17M | $-25M | $-28M | $-45M | $-19M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $18.0K | $19.0K | $29.0K | $107.0K | $-5.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-18.0K | $-17.0K | $-29.0K | $-107.0K | $5.0K | |
| Debt Issued | $0 | $19M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Debt Issued | · | $19M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $141M | $0 | $0 | $0 | $140M | $0 | $0 | $0 | $26M | $-41.0K | $117M | $27M | $1M | $440.0K | $0 | |
| Net Stock Activity | · | $141M | · | · | · | $140M | · | · | · | $26M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $8M | $362M | $187.0K | $0 | $166.0K | $140M | $155.0K | $-53.0K | $210.0K | $64M | $41.0K | $117M | $56M | $1M | $639.0K | $-1.0K | |
| Net Change in Cash | $-33M | $316M | $-36M | $-36M | $-38M | $95M | $-42M | $-22M | $-34M | $43M | $-28M | $100M | $31M | $-26M | $-30M | $-34M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M | · | · | · | $-28M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-22M | · | · | · | · | · | · |
Rentabilité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.6% | 21.4% | · | -54.8% | -13.4% | -5.7% | · | -14.1% | -15.6% | -14.6% | · | -12.8% | -12.6% | -10.9% | · | -16.4% | |
| ROE | -205.4% | 34.9% | · | -119.4% | -19.8% | -7.9% | · | -17.2% | -19.4% | -16.7% | · | -14.9% | -14.5% | -11.5% | · | -18.9% | |
| ROIC | -38.8% | -11.4% | · | -58.8% | -22.3% | -22.4% | · | -21.8% | -19.2% | -15.0% | · | -13.5% | -19.8% | -19.8% | · | -13.2% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 3.3 | · | 1.2 | 8.8 | 10.2 | · | 8.9 | 12.0 | 15.2 | · | 18.6 | 15.2 | 14.9 | · | 7.4 | |
| Quick Ratio | 1.2 | 3.0 | · | 0.9 | 7.1 | 8.7 | · | 7.9 | 10.4 | 13.5 | · | 16.2 | 11.6 | 10.4 | · | 5.9 | |
| Debt / Equity | 0.6 | 0.2 | · | 0.8 | 0.2 | 0.2 | · | 0.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.2 | · | 0.5 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.1 | · | -31.5 | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-339M | $-103M | · | $-232M | $-133M | $-130M | · | $-145M | $-135M | $-121M | · | $-104M | $-92M | $-85M | · | $-76M | |
| Market Cap | $1.92B | $746M | · | $550M | $262M | $266M | · | $431M | $413M | $569M | · | · | · | · | · | · | |
| Enterprise Value | $1.54B | $331M | · | $395M | $71M | $36M | · | $252M | · | · | · | · | · | · | · | · | |
| P/E | -3.5 | -2.3 | · | -2.2 | -1.6 | -1.5 | · | -2.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -5.0 | · | -5.9 | |
| P/B | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Cash Flow | · | -15.6 | · | · | · | -5.8 | · | · | · | -27.3 | · | · | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -27.3 | · | · | · | · | · | · | |
| EV / EBITDA | -29.4 | -7.7 | · | -9.8 | -1.7 | -0.7 | · | -5.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -28.5% | -43.2% | · | -46.2% | -63.2% | -66.8% | · | -37.1% | -10294.4% | -7473.4% | · | -8401.0% | -7506.0% | -20.1% | · | -16.9% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-288M | $-155M | $-118M | $-92M | $-72M |
| BPA dilué | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | -0.6 | 0.2 | — | — | — |
| Ratio de liquidité | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 |
| Ratio de liquidité réduite | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | $-119M | $-97M | $-106M | $-68M |
Dernières actualités Actualités récentes mentionnant cette entreprise
- La FDA accorde un examen continu et la désignation CNPV à Compass Pathways (CMPS) pour le traitement de la dépression résistante au traitement
- Trump envoie l'action Compass Pathways en flèche alors qu'il soutient les psychédéliques. Devriez-vous acheter CMPS ici ?
- Pourquoi le titre de Compass Pathways a-t-il bondi de 40 % aujourd'hui
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 250 déclarants · $1.3B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 66 (+6 vs T. préc.) | 30 (+7 vs T. préc.) | 77 (+3 vs T. préc.) | 53 (+26 vs T. préc.) | -2.0M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Deep Track Capital, LP | $172 085 168 | 12 161 496 | 13,73% | Actions |
| RTW INVESTMENTS, LP | $151 418 782 | 10 700 974 | 12,08% | Actions |
| BIT Capital GmbH | $89 835 478 | 6 348 797 | 7,17% | Actions |
| TANG CAPITAL MANAGEMENT LLC | $70 750 000 | 5 000 000 | 5,65% | Actions |
| TWO SIGMA INVESTMENTS, LP | $63 257 363 | 4 470 485 | 5,05% | Actions |
| ARK Investment Management LLC | $48 845 310 | 3 451 965 | 3,90% | Actions |
| Point72 Asset Management, L.P. | $37 085 424 | 2 620 878 | 2,96% | Actions |
| Logos Global Management LP | $31 837 500 | 2 250 000 | 2,54% | Actions |
| Eagle Health Investments LP | $29 155 042 | 2 060 427 | 2,33% | Actions |
| DAFNA Capital Management LLC | $28 469 121 | 2 011 952 | 2,27% | Actions |
| BANK OF AMERICA CORP /DE/ | $28 339 691 | 2 002 805 | 2,26% | Actions |
| Caption Management, LLC | $27 544 390 | 1 946 600 | 2,20% | Option d'achat |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $26 855 285 | 1 897 900 | 2,14% | Option d'achat |
| NEXTBio Capital Management LP | $25 126 990 | 1 775 759 | 2,00% | Actions |
| MARSHALL WACE, LLP | $20 935 350 | 1 479 530 | 1,67% | Actions |
| Aisling Capital Management LP | $20 267 554 | 1 432 336 | 1,62% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $20 261 229 | 1 431 889 | 1,62% | Actions |
| Candriam S.C.A. | $18 013 686 | 1 274 278 | 1,44% | Actions |
| Woodline Partners LP | $15 366 957 | 1 086 004 | 1,23% | Actions |
| Jefferies Financial Group Inc. | $14 070 661 | 994 393 | 1,12% | Actions |
| Trexquant Investment LP | $12 171 236 | 860 158 | 0,97% | Actions |
| Kalehua Capital Management LLC | $11 598 642 | 819 692 | 0,93% | Actions |
| MILLENNIUM MANAGEMENT LLC | $10 909 466 | 770 987 | 0,87% | Actions |
| Caption Management, LLC | $10 699 041 | 756 116 | 0,85% | Actions |
| Eversept Partners, LP | $9 520 474 | 672 825 | 0,76% | Actions |
| Propel Bio Management, LLC | $8 109 167 | 573 086 | 0,65% | Actions |
| Creek Drive Management Group LLC | $8 093 800 | 572 000 | 0,65% | Actions |
| Occam Crest Management LP | $7 739 000 | 710 000 | 0,62% | Actions |
| CITADEL ADVISORS LLC | $7 567 420 | 534 800 | 0,60% | Option d'achat |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 140 090 | 504 600 | 0,57% | Option de vente |
| SILVERARC CAPITAL MANAGEMENT, LLC | $7 122 855 | 503 382 | 0,57% | Actions |
| JANE STREET GROUP, LLC | $7 075 821 | 500 058 | 0,56% | Actions |
| Qube Research & Technologies Ltd | $7 070 415 | 499 676 | 0,56% | Actions |
| Walleye Capital LLC | $6 893 385 | 487 165 | 0,55% | Actions |
| Ensign Peak Advisors, Inc | $6 716 340 | 474 653 | 0,54% | Actions |
| Blue Owl Capital Holdings LP | $6 367 500 | 450 000 | 0,51% | Actions |
| AdvisorShares Investments LLC | $5 962 060 | 421 347 | 0,48% | Actions |
| CITADEL ADVISORS LLC | $5 952 679 | 420 684 | 0,47% | Actions |
| TWO SIGMA ADVISERS, LP | $5 909 850 | 856 500 | 0,47% | Actions |
| GOLDMAN SACHS GROUP INC | $5 540 956 | 391 587 | 0,44% | Actions |
| HighVista Strategies LLC | $5 251 349 | 371 120 | 0,42% | Actions |
| Legal & General Group Plc | $4 700 154 | 332 206 | 0,38% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $4 573 407 | 323 209 | 0,36% | Actions |
| Amova Asset Management Americas, Inc. | $4 517 334 | 319 472 | 0,36% | Actions |
| Squadron Capital Management LLC | $4 315 750 | 305 000 | 0,34% | Option d'achat |
| Affinity Asset Advisors, LLC | $4 261 739 | 301 183 | 0,34% | Actions |
| SEVEN GRAND MANAGERS, LLC | $4 245 000 | 300 000 | 0,34% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4 245 000 | 300 000 | 0,34% | Actions |
| Squadron Capital Management LLC | $4 245 000 | 300 000 | 0,34% | Actions |
| AMERIPRISE FINANCIAL INC | $4 081 271 | 288 429 | 0,33% | Actions |
| JANE STREET GROUP, LLC | $4 079 445 | 288 300 | 0,33% | Option d'achat |
| STEMPOINT CAPITAL LP | $4 029 481 | 284 769 | 0,32% | Actions |
| TORONTO DOMINION BANK | $3 930 233 | 277 755 | 0,31% | Actions |
| ROYCE & ASSOCIATES LP | $3 778 885 | 267 059 | 0,30% | Actions |
| PFM Health Sciences, LP | $3 503 384 | 247 589 | 0,28% | Actions |
| D. E. Shaw & Co., Inc. | $3 408 367 | 240 874 | 0,27% | Actions |
| Brown University | $3 030 930 | 214 200 | 0,24% | Actions |
| MORGAN STANLEY | $2 973 693 | 210 155 | 0,24% | Actions |
| Caption Management, LLC | $2 950 275 | 208 500 | 0,24% | Option de vente |
| HEIGHTS CAPITAL MANAGEMENT, INC | $2 913 938 | 205 932 | 0,23% | Actions |
| CITADEL ADVISORS LLC | $2 695 575 | 190 500 | 0,22% | Option de vente |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2 481 528 | 175 373 | 0,20% | Actions |
| Engineers Gate Manager LP | $2 432 343 | 171 897 | 0,19% | Actions |
| Y-Intercept (Hong Kong) Ltd | $2 378 474 | 168 090 | 0,19% | Actions |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $2 122 500 | 150 000 | 0,17% | Actions |
| Squarepoint Ops LLC | $1 962 195 | 138 671 | 0,16% | Actions |
| Balyasny Asset Management L.P. | $1 959 492 | 138 480 | 0,16% | Actions |
| ALPS ADVISORS INC | $1 930 937 | 136 462 | 0,15% | Actions |
| Founders Fund VII Management, LLC | $1 924 272 | 278 880 | 0,15% | Actions |
| K2 PRINCIPAL FUND, L.P. | $1 911 665 | 135 100 | 0,15% | Actions |
| WELLS FARGO & COMPANY/MN | $1 897 246 | 134 081 | 0,15% | Actions |
| CenterBook Partners LP | $1 777 155 | 125 594 | 0,14% | Actions |
| Creek Drive Management Group LLC | $1 698 000 | 120 000 | 0,14% | Option d'achat |
| BANK OF MONTREAL /CAN/ | $1 686 991 | 119 222 | 0,13% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $1 639 118 | 115 839 | 0,13% | Actions |
| Palo Alto Investors LP | $1 635 966 | 115 616 | 0,13% | Actions |
| Simplify Asset Management Inc. | $1 617 076 | 114 281 | 0,13% | Actions |
| LPL Financial LLC | $1 550 387 | 109 568 | 0,12% | Actions |
| GROUP ONE TRADING LLC | $1 390 917 | 98 298 | 0,11% | Actions |
| Susquehanna Portfolio Strategies, LLC | $1 341 448 | 94 802 | 0,11% | Actions |
| CreativeOne Wealth, LLC | $1 336 312 | 94 439 | 0,11% | Actions |
| STABLEFORD CAPITAL II LLC | $1 300 003 | 91 873 | 0,10% | Actions |
| STATE STREET CORP | $1 150 098 | 81 279 | 0,09% | Actions |
| Lion Point Capital, LP | $1 132 000 | 80 000 | 0,09% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 063 896 | 75 187 | 0,08% | Actions |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $1 016 635 | 71 847 | 0,08% | Actions |
| DLD Asset Management, LP | $990 500 | 70 000 | 0,08% | Option de vente |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $941 852 | 66 562 | 0,08% | Actions |
| Aquatic Capital Management LLC | $922 297 | 65 180 | 0,07% | Actions |
| JANE STREET GROUP, LLC | $915 505 | 64 700 | 0,07% | Option de vente |
| Dorsey Wright & Associates | $883 653 | 62 449 | 0,07% | Actions |
| Campbell & CO Investment Adviser LLC | $874 696 | 61 816 | 0,07% | Actions |
| STIFEL FINANCIAL CORP | $855 639 | 60 469 | 0,07% | Actions |
| Intellectus Partners, LLC | $841 925 | 59 500 | 0,07% | Actions |
| DCF Advisers, LLC | $767 638 | 54 250 | 0,06% | Actions |
| CIBC WORLD MARKET INC. | $737 357 | 52 110 | 0,06% | Actions |
| NATIONAL BANK OF CANADA /FI/ | $731 420 | 51 727 | 0,06% | Actions |
| FLAX POND CAPITAL, LLC | $728 951 | 51 516 | 0,06% | Actions |
| EXCHANGE TRADED CONCEPTS, LLC | $708 943 | 50 102 | 0,06% | Actions |
| PEAK6 LLC | $707 500 | 50 000 | 0,06% | Option d'achat |
Initiés de la société 9 initiés · 0 dirigeants · 0 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Kabir Nath | — | 3 août 2026 F | 361 028 | 0 | 0 | $0 |
| Robert Mcquade | — | 27 mai 2026 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | — | 27 mai 2026 A | — | 0 | 0 | $0 |
| Daphne Karydas | — | 27 mai 2026 A | — | 0 | 0 | $0 |
| Justin D. Gover | — | 27 mai 2026 A | — | 0 | 0 | $0 |
| David Y Norton | — | 27 mai 2026 A | — | 0 | 0 | $0 |
| Wayne Joseph Riley | — | 27 mai 2026 A | — | 0 | 0 | $0 |
| Gino Santini | — | 27 mai 2026 A | — | 0 | 0 | $0 |
| Jeffrey M Jonas | — | 27 mai 2026 A | — | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| AtaiBeckley Inc. | 17 février 2026 | 4,96% | Amendement | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 6 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2,43% | 3 316 076 NS | 30 avril 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,99% | 40 950 NS | 30 avril 2026 | N-PORT |
| BIB · ProShares Trust | 0,06% | 3 487 NS | 31 mai 2026 | N-PORT |
| APIE · Trust for Professional Managers | 0,03% | 21 455 NS | 31 mai 2026 | N-PORT |
| IBB · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 juillet 2026 | Quotidien |